Rights issue in PledPharma oversubscribed
Stockholm, 2013-05-24 14:00 CEST (GLOBE NEWSWIRE) --
PledPharmas rights issue with subscription period from 6 May to 20 May 2013 was
oversubscribed by 38 percent. PledPharma receives approximately SEK 18.6
million before issue costs.
The rights issue was subscribed to approximately 95 percent with preferential
rights and the remaining 5 percent were subscribed for without preferential
rights. The new share issue was, thus, fully subscribed. Shares subscribed for
without preferential rights, will be allocated to shareholders who exercised
subscription rights in relation to the number of existing subscription rights
used by each shareholder.
“The oversubscription shows great interest in PledPharma and PledOx®. The
rights issue is done to expand PLIANT study with more study centers worldwide
to ensure implementation, and also to achieve greater flexibility and time to
implement the best...